Yao Liangqing

Academic Leader in Shanghai Municipal Health System, Vice Chairman of the Ovarian Cancer Committee of the Chinese Anti-Cancer Association (Integrated Traditional Chinese and Western Medicine), Vice Chairman of the Tumor Genetics Branch of the Chinese Maternal and Child Health Association, Vice Chairman of the Gynecologic Oncology Committee of the Shanghai Anti-Cancer Association, and Deputy Editor-in-Chief of the *Chinese Journal of Metastatic Tumors*. Chief Expert of the Ovarian Cancer Team of the Fudan University Medical Consortium. Formerly Deputy Director of the Women and Children's Medical Center Affiliated to Guangzhou Medical University. Leading her team in the field of ovarian cancer for over ten years, performing over a thousand surgeries annually with a satisfactory tumor reduction rate approaching 90%, reaching top international standards. Specializes in minimally invasive surgery, chemotherapy, targeted therapy, and comprehensive treatment of ovarian cancer, cervical cancer, endometrial cancer, vulvar cancer, vaginal cancer, and trophoblastic tumors, including multidisciplinary surgery for ovarian cancer, salvage surgery for recurrent gynecologic malignancies, and the development of multi-line treatment strategies. One of the founding members of the ESEG International Gynecologic Oncology Master Training Program. Appointed as the first director of the Department of Gynecologic Oncology after its independent establishment in 2019. He received the second prize of Natural Science Award from the Ministry of Education. He has been responsible for 12 research projects of various types; published nearly 40 papers in SCI and Chinese journals; and obtained 3 invention patents.